1. Ameen R, Al Shemmari S, Al-Bashir A. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion. 2009;49(8):1649–54.
2. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol. 2001 Jan;38(1 Suppl 1):14–22.
3. Allain JP, Stramer SL, Carneiro-Proietti AB, Martins ML, Lopes da Silva SN, Ribeiro M, et al. Transfusion-transmitted infectious diseases. Biologicals. 2009 Apr;37(2):71–7.
4. Sivapalaratnam S, Linpower L, Sirigireddy B, Agapidou A, Jain S, Win N, et al. Treatment of post-transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti-IL6R humanised monoclonal antibody tocilizumab. Br J Haematol. 2019;186(6):e212–4.
5. Gouveia ME, Soares NB, Santoro MS, de Azevedo FC. Hyperhemolysis syndrome in a patient with sickle cell anemia: case report. Rev Bras Hematol Hemoter. 2015;37(4):266–8.